Compare GLP-1 medications
Start with the brands you know, or compare active ingredients. Approved uses, formulations, prices, and study evidence stay distinct.
Choose what to compare
Compare the named products. Different brands of the same ingredient stay separate. Missing label or price details are shown explicitly.
orforglipron
semaglutide
Every approved GLP-1 side by side
Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.
| Brand | Soonest top dose | Half-life | Generic approved? | Patent on the medicine to | On Medicare Part D, 2025 |
|---|---|---|---|---|---|
| Ozempic | 2 mg from week 13 | about 1 week | Not yet: tentative only | Dec 5, 2031 | 2,044,798 |
| Wegovy | 7.2 mg from week 21 | about 1 week | No | Dec 5, 2031 | 108,843 |
| Rybelsus | 14 mg from day 61 | about one week | No | May 2, 2034 | 280,455 |
| Mounjaro | 15 mg from week 21 | about 5 days | No | Jun 14, 2039 | 1,592,517 |
| Zepbound | 15 mg from week 21 | about 5-6 days | No | May 13, 2036 | 160,298 |
| Foundayo | 17.2 mg from day 151 | about 29 to 49 hours | No | Sep 26, 2037 | None listed |
| Victoza | 1.8 mg from week 3 | about 13 hours | Yes, 8 | None listed | 6,810 |
| Saxenda | 3 mg from week 5 | about 13 hours | Yes, 3 | None listed | None listed |
| Trulicity | 4.5 mg from week 13 | about 5 days | No, it is a biologic | Not in the Orange Book | 582,333 |
How long each takes · Generics and patents · Who covers what
Start with a familiar pair
Product-specific labels and prices, including differences between injections and tablets.
Semaglutide and Tirzepatide: compare the actual brands.
MounjaroOzempicTirzepatide and Semaglutide: compare the actual brands.
OzempicWegovySame ingredient (semaglutide), different approved uses.
MounjaroZepboundSame ingredient (tirzepatide), different approved uses.
OzempicRybelsusSame ingredient (semaglutide), different approved uses.
SaxendaWegovyLiraglutide and Semaglutide: compare the actual brands.
WegovyWegovy HDSame ingredient (semaglutide), different approved uses.
MounjaroWegovyTirzepatide and Semaglutide: compare the actual brands.
OzempicZepboundSemaglutide and Tirzepatide: compare the actual brands.
SaxendaVictozaSame ingredient (liraglutide), different approved uses.
OzempicTrulicitySemaglutide and Dulaglutide: compare the actual brands.
MounjaroTrulicityTirzepatide and Dulaglutide: compare the actual brands.
RybelsusWegovySame ingredient (semaglutide), different approved uses.
SaxendaZepboundLiraglutide and Tirzepatide: compare the actual brands.
TrulicityVictozaDulaglutide and Liraglutide: compare the actual brands.
FoundayoWegovyOrforglipron and Semaglutide: compare the actual brands.
FoundayoZepboundOrforglipron and Tirzepatide: compare the actual brands.
Browse all 15 approved-ingredient pairs
Ingredient comparisons cover multiple brands and formulations. Trial results include the studied dose and population.
Ozempic, Wegovy, Wegovy HD, Rybelsus
Ozempic, Wegovy, Wegovy HD, Rybelsus
Ozempic, Wegovy, Wegovy HD, Rybelsus
Ozempic, Wegovy, Wegovy HD, Rybelsus
Ozempic, Wegovy, Wegovy HD, Rybelsus
Mounjaro, Zepbound, Victoza, Saxenda
Mounjaro, Zepbound, Trulicity
Mounjaro, Zepbound, Byetta (discontinued), Bydureon BCise (discontinued)
Mounjaro, Zepbound, Foundayo
Victoza, Saxenda, Trulicity
Victoza, Saxenda, Byetta (discontinued), Bydureon BCise (discontinued)
Victoza, Saxenda, Foundayo
Trulicity, Byetta (discontinued), Bydureon BCise (discontinued), Generic exenatide
Trulicity, Foundayo
Byetta (discontinued), Bydureon BCise (discontinued), Generic exenatide, Foundayo
Comparing GLP-1s: common questions
Which GLP-1 is best?
None is best for everyone: it depends on what it is for, what you tolerate and what you can get. In SURMOUNT-5, a head-to-head trial of the injections, mean weight change was −13.7% on semaglutide (Wegovy) and −20.2% on tirzepatide (Zepbound) over 72 weeks. Your prescriber weighs these against your health and history. Semaglutide vs tirzepatide, compared in full
Which GLP-1 has the most weight loss?
Compare only within a head-to-head trial, because separate trials enrolled different people. In SURMOUNT-5, a head-to-head trial of the injections, mean weight change was −13.7% on semaglutide (Wegovy) and −20.2% on tirzepatide (Zepbound) over 72 weeks. Weight loss and A1c results compared
Which GLP-1 has the fewest side effects?
No trial compares them all, and each label's rates come from its own trials. The side effects page shows each rate beside its own placebo group. GLP-1 side effects compared